Your browser doesn't support javascript.
loading
A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma.
Bond, David A; Huang, Ying; Christian, Beth A; Jaglowski, Samantha; Benson, Don; Alinari, Lapo; Baiocchi, Robert A; Cohen, Jonathon B; Blum, Kristie A; Maddocks, Kami J.
Afiliação
  • Bond DA; Department of Internal Medicine, Division of Hematology b. Department of Hematology and Medical Oncology.
  • Huang Y; Department of Internal Medicine, Division of Hematology b. Department of Hematology and Medical Oncology.
  • Christian BA; Department of Internal Medicine, Division of Hematology b. Department of Hematology and Medical Oncology.
  • Jaglowski S; Department of Internal Medicine, Division of Hematology b. Department of Hematology and Medical Oncology.
  • Benson D; Department of Internal Medicine, Division of Hematology b. Department of Hematology and Medical Oncology.
  • Alinari L; Department of Internal Medicine, Division of Hematology b. Department of Hematology and Medical Oncology.
  • Baiocchi RA; Department of Internal Medicine, Division of Hematology b. Department of Hematology and Medical Oncology.
  • Cohen JB; Emory University, Atlanta, GA, USA.
  • Blum KA; Department of Internal Medicine, Division of Hematology b. Department of Hematology and Medical Oncology.
  • Maddocks KJ; Emory University, Atlanta, GA, USA.
Leuk Lymphoma ; 63(7): 1750-1753, 2022 07.
Article em En | MEDLINE | ID: mdl-35129029
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2022 Tipo de documento: Article